A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Fung, Scott ^{[3
]}

Ahn, Sang Hoon ^{[4
]}

Chuang, Wan-Long ^{[5
]}

Ramji, Alnoor ^{[6
]}

Tak, Won Young ^{[7
]}

Chen, Chiyi ^{[8
]}

Tam, Edward ^{[9
]}

Bae, Ho ^{[10
]}

Ma, Xiaoli ^{[11
]}

Flaherty, John F. ^{[12
]}

Gaggar, Anuj ^{[12
]}

Lau, Audrey ^{[12
]}

Feierbach, Becket ^{[12
]}

Wu, George ^{[12
]}

Suri, Vithika ^{[12
]}

Subramanian, Mani ^{[12
]}

Trinh, Huy N. ^{[13
]}

Yoon, Seung Kew ^{[14
]}

Agarwal, Kosh ^{[15
]}

Lim, Young-Suk ^{[16
]}

Chan, Henry ^{[17
]}

机构：

[1] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[2] Univ Hosp Vall dHebron, Barcelona, Spain

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Yonsei Univ, Seoul, South Korea

[5] Kaohsiung Med Univ, Kaohsiung, Taiwan

[6] Gastrointestinal Res Inst, Vancouver, BC, Canada

[7] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[8] Chia Yi Christian Hosp, Chiayi, Taiwan

[9] LAIR Ctr, Vancouver, BC, Canada

[10] St Vincents Med Ctr, Los Angeles, CA USA

[11] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[12] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] San Jose Gastroenterol, San Jose, CA USA

[14] Catholic Univ Korea, Seoul, South Korea

[15] Kings Coll Hosp London, London, England

[16] Univ Ulsan, Coll Med, Seoul, South Korea

[17] Prince Wales Hosp, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30928-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-183

引用

页码：E470 / E471

页数：2

共 50 条

[1] A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS
Chan, Henry Lik Yuen
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
GUT, 2019, 68 : A142 - A143
[2] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
Lampertico, Pietro
Buti, Maria
Ramji, Alnoor
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Yoon, Seung Kew
Kao, Jia-Horng
Chen, Chi-Yi
Tam, Edward
Khalili, Mandana
Bae, Ho
Ma, Xiaoli
Tak, Won Young
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Tan, Susanna
Liu, Yang
Wu, George
Subramanian, Mani
Hann, Hie-Won
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry
JOURNAL OF HEPATOLOGY, 2020, 73 : S67 - S68
[3] A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety Results
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, G. Mani
Oberle, Corinna
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L. Y.
SWISS MEDICAL WEEKLY, 2019, : 25S - 25S
[4] EFFICACY AND SAFETY RESULTS 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) VS CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Trinh, Huy N.
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L.
GASTROENTEROLOGY, 2019, 156 (06) : S1195 - S1195
[5] A Phase 3 Study Comparing Switching: Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Final Week 96 Results
Khalili, Mandana
Lampertico, Pietro
Bae, Ho S.
Ma, Xiaoli
Ramji, Alnoor
Fung, Scott
Ahn, Sang Hoon
Kao, Jia-Horng
Tam, Edward
Halton, Patricia
Yee, Leland
Flaherty, John
Gaggar, Anuj
Liu, Yang
Wu, George
Hann, Hie-Won
Agarwal, Kosh
Lim, Young-Suk
Buti, Maria
Chan, Henry
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S543 - S543
[6] 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) SWITCH VS. CONTINUED TDF TREATMENT AMONG VIROLOGICALLY-SUPPRESSED HEPATITIS B PATIENTS OF ASIAN ETHNICITY
Ahn, Sang Hoon
Kao, Jia-Horng
Lampertico, Pietro
Ramji, Alnoor
Fung, Scott
Chuang, Wan-Long
Kim, Yoon Jun
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Lee, June Sung
Chan, Carol Yee Kwan
Yee, Leland J.
Sethi, Shalini
Flaherty, John
Zhao, Yang
Gaggar, Anuj
Hann, Hie Won
Lim, Young-Suk
Chan, Henry Lik Yuen
GUT, 2021, 70 : A77 - A78
[7] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-negative, chronic hepatitis B (CHB): Week 48 efficacy and safety results
Cheng, W.
Pianko, S.
Thompson, A.
Buti, M.
Gane, E.
Seto, W. K.
Chan, H. L. Y.
Chuang, W-L
Stepanova, T.
Hui, A-J
Lim, Y-S
Mehta, R.
Janssen, H.
Acharya, S. K.
Flaherty, J. F.
Massetto, B.
Cathcart, A.
Dinh, P.
Subramanian, G. M.
Mchutchison, J. G.
Pan, C.
Brunetto, M.
Izumi, N.
Marcellin, P.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 68 - 69
[8] A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
Agarwal, K.
Fung, S.
Seto, W. K.
Lim, Y. S.
Gane, E.
Janssen, H. L.
Sharma, M.
Chuang, W. L.
Bae, H.
Yoon, K. T.
Flaherty, J. F.
Lau, A.
Gaggar, A.
Suri, V.
Cathcart, A.
Lin, L.
Subramanian, G. M.
Shalimar
Furusyo, N.
Buti, M.
Chan, H. L.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S478 - S478
[9] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
Nam, Heechul
Han, Ji Won
Lee, Soon Kyu
Yang, Hyun
Lee, Hae Lim
Sung, Pil Soo
Song, Myeong Jun
Kwon, Jung Hyun
Jang, Jeong Won
Chang, U-Im
Kim, Chang Wook
Nam, Soon Woo
Bae, Si Hyun
Choi, Jong Young
Yoon, Seung Kew
Yang, Jin Mo
Kim, Hee Yeon
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1673 - 1683
[10] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
Agarwal, Kosh
Fung, Scott
Seto, Wai-Kay
Lim, Young-Suk
Gane, Edward
Janssen, Harry L.
Chuang, Wan-Long
Bae, Ho
Yoon, Ki Tae
Flaherty, John F.
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Cathcart, Andrea
Lin, Lanjia
Chan, Alain
Shalimar, Mani Subramanian
Furusyo, Norihiro
Buti, Maria
Chan, Henry L.
GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086

← 1 2 3 4 5 →